# Unicycive Therapeutics, Inc.: filings

UNCY · Nasdaq · CIK 1766140 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uncy.md) · [Financials](/companies/uncy/financials.md) · [Filings](/companies/uncy/filings.md) · [Insiders](/companies/uncy/insiders.md)

## Reports and events: 103 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 70, 4 49, SCHEDULE 13G/A 26, 10-Q 16, CORRESP 16, SC 13G/A 12, DEFA14A 11, SC 13G 11, 3 10, UPLOAD 10, 4/A 9, EFFECT 7, 10-K 5, D 5, DEF 14A 5, S-1/A 5, S-3 5, ARS 4, DRSLTR 4, S-8 4, DRS/A 3, PRE 14A 3, 424B5 2, SEC STAFF LETTER 2, 144 1, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-Q 1, POS AM 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 07:46 ET | [8-K](/filings/0001213900-26-104314.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-104314 |
| 2026-09-28 | 16:31 ET | [8-K](/filings/0001213900-26-104076.md) | 8.01 Other events | 0001213900-26-104076 |
| 2026-08-12 | 08:04 ET | [8-K](/filings/0001213900-26-088061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088061 |
| 2026-08-12 | 06:30 ET | [10-Q](/filings/0001213900-26-088013.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088013 |
| 2026-07-02 | 10:30 ET | [8-K](/filings/0001213900-26-074678.md) | 8.01 Other events | 0001213900-26-074678 |
| 2026-06-22 | 06:05 ET | [8-K](/filings/0001213900-26-070316.md) | 5.07 Shareholder vote results | 0001213900-26-070316 |
| 2026-06-05 | 16:19 ET | [8-K](/filings/0001213900-26-065828.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-065828 |
| 2026-05-12 | 07:51 ET | [8-K](/filings/0001213900-26-054736.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054736 |
| 2026-05-12 | 06:30 ET | [10-Q](/filings/0001213900-26-054708.md) | Quarterly report, period 2026-03-31 | 0001213900-26-054708 |
| 2026-04-30 | 07:00 ET | [DEF 14A](/filings/0001213900-26-049690.md) | Proxy statement, period 2026-06-19 | 0001213900-26-049690 |
| 2026-04-06 | 09:11 ET | [8-K](/filings/0001213900-26-040179.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-040179 |
| 2026-03-30 | 07:29 ET | [8-K](/filings/0001213900-26-035961.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-035961 |
| 2026-03-30 | 06:32 ET | [10-K](/filings/0001213900-26-035903.md) | Annual report, period 2025-12-31 | 0001213900-26-035903 |
| 2025-11-14 | 17:10 ET | [8-K](/filings/0001213900-25-111045.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-111045 |
| 2025-11-12 | 09:12 ET | [8-K](/filings/0001213900-25-108847.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-108847 |
| 2025-11-12 | 06:39 ET | [10-Q](/filings/0001213900-25-108600.md) | Quarterly report, period 2025-09-30 | 0001213900-25-108600 |
| 2025-10-28 | 07:30 ET | [8-K](/filings/0001213900-25-102790.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-102790 |
| 2025-08-18 | 16:17 ET | [8-K](/filings/0001213900-25-077937.md) | 8.01 Other events | 0001213900-25-077937 |
| 2025-08-15 | 16:30 ET | [8-K](/filings/0001213900-25-077497.md) | 8.01 Other events | 0001213900-25-077497 |
| 2025-08-14 | 08:15 ET | [8-K](/filings/0001213900-25-076066.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076066 |
| 2025-08-14 | 06:39 ET | [10-Q](/filings/0001213900-25-076007.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076007 |
| 2025-07-08 | 09:05 ET | [8-K](/filings/0001213900-25-061936.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-061936 |
| 2025-06-30 | 09:25 ET | [8-K](/filings/0001213900-25-059303.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059303 |
| 2025-06-20 | 16:10 ET | [8-K](/filings/0001213900-25-056188.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056188 |
| 2025-06-10 | 09:29 ET | [8-K](/filings/0001213900-25-052824.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-052824 |
| 2025-06-09 | 10:38 ET | [8-K](/filings/0001213900-25-052413.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-052413 |
| 2025-05-21 | 09:17 ET | [8-K](/filings/0001213900-25-046244.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-046244 |
| 2025-05-14 | 08:01 ET | [8-K](/filings/0001213900-25-042967.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-042967 |
| 2025-05-14 | 07:05 ET | [10-Q](/filings/0001213900-25-042943.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042943 |
| 2025-04-30 | 16:06 ET | [DEF 14A](/filings/0001213900-25-037613.md) | Proxy statement, period 2025-06-09 | 0001213900-25-037613 |
| 2025-04-14 | 16:30 ET | [8-K/A](/filings/0001213900-25-031593.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-031593 |
| 2025-03-31 | 16:15 ET | [8-K](/filings/0001213900-25-026270.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-026270 |
| 2025-03-31 | 09:15 ET | [10-K](/filings/0001213900-25-025828.md) | Annual report, period 2024-12-31 | 0001213900-25-025828 |
| 2025-01-07 | 16:15 ET | [8-K](/filings/0001213900-25-001640.md) | 8.01 Other events | 0001213900-25-001640 |
| 2024-11-13 | 08:04 ET | [8-K](/filings/0001213900-24-097145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097145 |
| 2024-11-13 | 07:05 ET | [10-Q](/filings/0001213900-24-097118.md) | Quarterly report, period 2024-09-30 | 0001213900-24-097118 |
| 2024-11-12 | 06:05 ET | [8-K](/filings/0001213900-24-096104.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-096104 |
| 2024-09-25 | 20:54 ET | [8-K](/filings/0001213900-24-081531.md) | 8.01 Other events | 0001213900-24-081531 |
| 2024-08-14 | 08:11 ET | [8-K](/filings/0001213900-24-068597.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-068597 |
| 2024-08-14 | 07:05 ET | [10-Q](/filings/0001213900-24-068565.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068565 |
| 2024-07-15 | 16:15 ET | [8-K](/filings/0001213900-24-061355.md) | 3.01 Delisting notice | 0001213900-24-061355 |
| 2024-07-15 | 16:15 ET | [8-K](/filings/0001213900-24-061354.md) | 3.01 Delisting notice | 0001213900-24-061354 |
| 2024-07-02 | 16:15 ET | [8-K](/filings/0001213900-24-058621.md) | 1.01 Entry into a material agreement | 0001213900-24-058621 |
| 2024-06-26 | 17:20 ET | [8-K](/filings/0001213900-24-056224.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-056224 |
| 2024-06-25 | 09:15 ET | [8-K](/filings/0001213900-24-055436.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-055436 |
| 2024-06-20 | 16:05 ET | [8-K](/filings/0001213900-24-054279.md) | 5.07 Shareholder vote results | 0001213900-24-054279 |
| 2024-05-13 | 16:28 ET | [8-K](/filings/0001213900-24-042338.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-042338 |
| 2024-05-13 | 16:06 ET | [10-Q](/filings/0001213900-24-042298.md) | Quarterly report, period 2024-03-31 | 0001213900-24-042298 |
| 2024-04-26 | 17:10 ET | [DEF 14A](/filings/0001213900-24-036716.md) | Proxy statement, period 2024-06-20 | 0001213900-24-036716 |
| 2024-03-29 | 17:31 ET | [8-K](/filings/0001213900-24-027373.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-027373 |

Page 1 of 3. [Older](/companies/uncy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.